Moreover, reclassification of T cells in SCLC patients can better mirror the expression pattern of T cells dysfunction and exhaustion markers (such as HAVCR2, CTLA4, LAYN, PDCD1, LAG3, TIGIT), which may be used as immunotherapeutic targets. Here, LAG3 is linked to small cell lung carcinoma.